Cancer Care

 

 
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer
Principal Investigator (?)
Study Number
D1022
Summary
- The primary objective is to determine the reduction in pain score by ketamine mouthwash
compared to placebo in head and neck cancer patients with refractory mucositis.

- The secondary objectives are to describe the duration of analgesia and adverse effects
associated with ketamine and placebo.
Phase (?)
Phase II
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.